Higher-Calorie Refeeding in Anorexia Nervosa: 1-Year Outcomes From a Randomized Controlled Trial

Neville H Golden, Jing Cheng, Cynthia J Kapphahn, Sara M Buckelew, Vanessa I Machen, Anna Kreiter, Erin C Accurso, Sally H Adams, Daniel Le Grange, Anna-Barbara Moscicki, Allyson F Sy, Leslie Wilson, Andrea K Garber, Neville H Golden, Jing Cheng, Cynthia J Kapphahn, Sara M Buckelew, Vanessa I Machen, Anna Kreiter, Erin C Accurso, Sally H Adams, Daniel Le Grange, Anna-Barbara Moscicki, Allyson F Sy, Leslie Wilson, Andrea K Garber

Abstract

Background and objectives: We recently reported the short-term results of this trial revealing that higher-calorie refeeding (HCR) restored medical stability earlier, with no increase in safety events and significant savings associated with shorter length of stay, in comparison with lower-calorie refeeding (LCR) in hospitalized adolescents with anorexia nervosa. Here, we report the 1-year outcomes, including rates of clinical remission and rehospitalizations.

Methods: In this multicenter, randomized controlled trial, eligible patients admitted for medical instability to 2 tertiary care eating disorder programs were randomly assigned to HCR (2000 kcals per day, increasing by 200 kcals per day) or LCR (1400 kcals per day, increasing by 200 kcals every other day) within 24 hours of admission and followed-up at 10 days and 1, 3, 6, and 12 months post discharge. Clinical remission at 12 months post discharge was defined as weight restoration (≥95% median BMI) plus psychological recovery. With generalized linear mixed effect models, we examined differences in clinical remission over time.

Results: Of 120 enrollees, 111 were included in modified intent-to-treat analyses, 60 received HCR, and 51 received LCR. Clinical remission rates changed over time in both groups, with no evidence of significant group differences (P = .42). Medical rehospitalization rates within 1-year post discharge (32.8% [19 of 58] vs 35.4% [17 of 48], P = .84), number of rehospitalizations (2.4 [SD: 2.2] vs 2.0 [SD: 1.6]; P = .52), and total number of days rehospitalized (6.0 [SD: 14.8] vs 5.1 [SD: 10.3] days; P = .81) did not differ by HCR versus LCR.

Conclusions: The finding that clinical remission and medical rehospitalization did not differ over 1-year, in conjunction with the end-of-treatment outcomes, support the superior efficacy of HCR as compared with LCR.

Trial registration: ClinicalTrials.gov NCT02488109.

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: Dr Le Grange receives royalties from Guilford Press and Routledge and is codirector of the Training Institute for Child and Adolescent Eating Disorders; the other authors have indicated they have no potential conflicts of interest to disclose.

Copyright © 2021 by the American Academy of Pediatrics.

Figures

FIGURE 1
FIGURE 1
Consolidated Standards of Reporting Trials diagram: RCT of HCR, compared with LCR, in hospitalized adolescents with AN.
FIGURE 2
FIGURE 2
Changes in rates of clinical remission over time: HCR versus LCR by using an mITT analysis.
FIGURE 3
FIGURE 3
Changes in percentage mBMI (mean ± SD) by treatment group over time: HCR versus LCR.

Source: PubMed

3
Suscribir